As demonstrated with PTC25816, PTC680 significantly increases ELP1 exon 20 inclusion in the FD retina (Fig. 4C; Supplemental Figs. 4, 5, 6), providing evidence that this novel splicing modulator mitigates a primary FD phenotype by increasing human ELP1 in the retina. This evidence concerns the gene ELP1 and Fabry disease.